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convective albumin loss
TORU SHINZATO, MASAMIKI MIwA, SHIGERU NAI, ICHIRO TAKAI, Y0sHIHIR0 MATSUMOTO,
HIROYUKI MORITA, TosHlo MIYATA, and KENJI MAEDA
Department of Internal Medicine, The Branch Hospita4 Nagoya University School of Medicine, Nagoya, Japan
Alternate repetition of short fore- and backfiltrations reduces convec-
tive albumin loss. An effective therapeutic means to remove relatively
large polypeptide uremic toxins seems to be a hemofiltration (HF) or
hemodiafiltration (HDF) employing a larger-pore membrane, that is, a
protein-permeable membrane. With either method, however, a significant
amount of albumin will be lost into the ultrafiltrate or dialysate. Now,
repetition of alternate short fore- and backfiltrations may prevent the
development of the ultrafiltration-induced higher albumin concentration
on the membrane surface (protein concentration polarization), where a
single forefiltration time is shorter than the time needed for completion of
protein concentration polarization. Since the albumin concentration on
the protein-permeable membrane surface will be one of the determinants
of albumin loss by convection, such HDF treatment may reduce protein
loss into the dialysate. To examine this assumption, we alternately repeated
short and rapid fore- and backfiltrations (push/pull HDF) through a protein-
permeable membrane, each less than 1 second in duration and at each
filtration volume of 15 ml, where a pyrogen-free dialysate was supplied. The
present results indicated that the albumin amount lost by push/pull HDF was
approximately one-third of that by conventional HDF. Nevertheless, the
reduction rates of /32-microglobulin and myoglobin were significantly greater
by push/pull HDF than by conventional HDF.
Some uremic toxins may belong to relatively large polypeptides.
For example, complement factor D (molecular wt 23,000 daltons)
accumulates in the body of renal failure patients [1], and excess
complement factor D may promote activation of the alternative
pathway [21.
An effective therapeutic means to remove such relatively large
polypeptide uremic toxins seems to be a hemofiltration (HF) or
hemodiafiltration (HDF) employing a larger-pore membrane
(that is, a protein-permeable membrane). With either method,
however, a significant amount of albumin will be lost into the
ultrafiltrate or dialysate [3].
Theoretically, when a protein-permeable membrane is em-
ployed with HF or HDF, the ultrafiltration-induced higher albu-
min concentration on the blood-side membrane surface (protein
concentration polarization [4, 5]) is a factor determining albumin
loss into ultrafiltrate or dialysate, as well as the ultrafiltration
volume and membrane pore size. Now, alternate repetition of
short fore- and backfiltrations may prevent the development of
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protein concentration polarization, when a single forefiltration
time is short enough compared to the time needed for completion
of protein concentration polarization. If so, during HDF based on
alternate repetition of short fore- and backfiltrations, albumin loss
through a protein-permeable membrane will diminish.
In order to examine this assumption, we first quickly applied
400 mm Hg of transmembrane pressure (TMP) to the high-flux
hemodiafilter in vivo and observed the change in ultrafiltration
rate with time following the TMP application, to estimate the time
needed for completion of protein concentration polarization
associated with ultrafiltration. Secondly, we alternately repeated
short and rapid fore- and backfiltrations through a protein-
permeable membrane, each for less than one second of duration,
where a sterile pyrogen-free dialysate was supplied.
Methods
To estimate the time needed for completion of protein concen-
tration polarization associated with ultrafiltration, an in vivo
experiment was carried out with six hemodialysis (HD) patients.
The mean hematocrit value of the patients was 28.9 1.5%, and
their mean serum concentration of total protein was 5.8 0.3 g/dl.
Five minutes after the start of HD using the protein-permeable
membrane, dialysate flow was stopped, the dialysate inlet was
tightly closed with a metal cap, and the dialysate outlet was
connected to a vinyl chloride tube (30 cm in length and 8 mm in
inner diameter), which was filled with dialysate, via the closed
solenoid valve system (Model AV-3202-53-S; Shibuya Industries
Ltd., Kanazawa, Japan). The other tip of the tube was connected
to an almost deflated plastic bag containing only a small amount
of dialysate.
Four hundred mm Hg of pressure was applied to the blood
compartment of the hemodiafilter by inflating the cuff placed in
the blood tubing downstream of the hemodiafilter. In this situa-
tion, the TMP is zero, because the dialysate inlet and outlet were
tightly closed, In this setting, the solenoid valve was opened so
that 400 mm Hg of TMP suddenly developed in the hemodiafilter.
After the solenoid valve was opened, the variation of ultrafiltra-
tion rate was determined by monitoring the weight of the plastic
bag using an electronic balancer (HX-400'; A&D Co. Ltd.,
Tokyo, Japan).
To perform short and rapid fore- and backfiltrations alter-
nately, the new-type of push/pull hemodiafiltration (push/pull
HDF) equipment [6] was employed with a volumetric dialysate
flow control system (DBB-11'; Nikkiso Co., Ltd., Tokyo, Japan)
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on the condition that a pyrogen-free dialysate was supplied. In the
present study, with the new equipment, the TMP (that is, the
difference between blood side pressure and dialysate side pres-
sure) was set to +400 mm Hg during forefiltration phase and
—400 mm Hg during backfiltration phase. In these conditions, the
time and volume of a single forefiltration were 0.8 to 0.9 seconds
and 15 ml, respectively, and the time and volume of a single
backfiltration were almost equivalent to these values [6].
Conventional post-replacement HDF (conventional HDF) was
performed by combining HDF equipment (TR 80'; Toray Co.,
Ltd., Tokyo, Japan) with the same volumetric dialysate flow
control system used with push/pull HDF. Conventional HD was
performed also using the same volumetric dialysate flow control
system.
The high-flux protein-permeable membrane manufactured for
trial by Asahi Medical Co., Ltd. (Tokyo, Japan) was employed for
the hemodiafilter in every form of treatment. The membrane
material of the hemodiafilter was polyacrylonitrile, and the mem-
brane area was 1.3 m2. According to the manufacturer, the sieving
coefficient was 0.82 for 132-microglobulin (f32m; 11,800 daltons),
0.47 for myoglobin (17,000 daltons), 0.30 for prolactin (22,000
daltons), 0.05 for a1-acid glycoprotein (cs1AG; 40,000 daltons) and
0.009 for albumin (66,000 daltons) when human serum added by
the tracer substances was used as a blood substitute in vitro.
For preparation of pyrogen-free dialysate, tap water was made
to pass through a particle filter and charcoal filter and then enter
a reverse-osmosis unit. Next, this reverse-osmosis water was sent
to the volumetric ultrafiltration controller, where it was mixed
with dialysate concentrates. The thus-produced dialysate was then
passed through a polysulfon pyrogen filter (CF609R, cutoff point
of 6,000 daltons; Nipro Co., Ltd.; Osaka, Japan) and polyester-
polymer alloy pyrogen filter (EF01R; cutoff point of 20,000
daltons; Nikkiso Co., Ltd., Tokyo, Japan) before being supplied to
the hemodiafilter. The polyester-polymer alloy filter removes
endotoxins by not only filtration but also adhesion [7].
Twelve anuric end-stage renal failure patients were selected for
the present study. Their mean age was 51.8 6.9 years, and
averaged 10.2 3.1 years on HD. Their body weight was 53.8
2.4 kg, and their predialysis hematocrit and serum albumin
concentration were 29.2 2.2% and 4.1 0.4 g/dl, respectively,
immediately before the experiments. In these patients, the first
HD of any given week was performed using the above protein-
permeable membrane, the first treatment of the next week was
performed by push/pull HDF using the same membrane, and the
first treatment of the third week was done by conventional HDF
using the same membrane. Each treatment lasted four hours,
blood flow rate was 220 ml/min, and excessive body water was
removed at a constant rate. With any of the three treatments, the
dialysate was supplied to the hemodiafilter at a rate of 500 mI/rn in.
During the conventional HDF, the body fluid was replaced at a
rate of 60 mI/mm by commercially available biological fluid
stocked in bottles (SubloodAR; Fuso Pharmaceutical Industries,
Ltd., Osaka, Japan). The composition of the dialysate was Na 140
rnEq/liter, K 2.0 mEq/Iiter, Ca 3.0 mEq/liter, Mg 1.0 mEq/liter, Cl
110 mEq/Iiter, acetate 8 mEq/liter, bicarbonate 30 mEq/liter and
glucose 100 mg/dl, whereas the composition of the replacement
fluid used for conventional HDF was Na 140 mEq/liter, K 2.0
mEq/liter, Ca 3.5 mEq/liter, Mg 1.5 mEq/liter, Cl 107 mEq/liter,
and acetate 40 mEq/liter.
The total ultrafiltration volume by push/pull HDF was evalu-
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Fig. 1. Variation in ultrafiltration rate following sudden development of
TMP. When 400 mm Hg of TMP suddenly developed in a hemodiafilter,
rapid ultrafiltration occurred immediately after the development, but it
decreased quickly to reach a stable rate at 2 seconds following the
development of TMP.
ated by the method described elsewhere [6], whereas that by
conventional HDF was calculated by adding the infusion volume
of replacement fluid to the net removal volume of body water
during the treatment.
The reduction rate is a lumped parameter reflecting diffusive,
convective and adsorptive removal of urernic substances. Never-
theless, in the present study, the reduction rate (R) determined
using the following equation was used to assess the removal of the
tracer substances by the three treatments because of its practical-
ity:
C1 - C2R= C xlOO (Eq.1)
where C1 indicates the pretreatment concentration of a substance
in question, and C2 denotes the post-treatment concentration of
the same which was corrected for extracellular volume change
according to Bergstrom and Wehle [8]. With each HD, push/pull
HDF or conventional HDF treatment, albumin loss into the
dialysate was evaluated on the basis of the whole dialysate volume
flowing out from the hemodiafilter and its albumin concentration.
The albumin concentration in the dialysate and the serum
concentrations of 2m, myoglobin and prolactin were determined
by radioimmunoassay. The serum concentration of a1AG was
measured by the single radial immunodiffusion method.
Statistical significance (defined as P < 0.05) was evaluated by
means of the paired Student's t-test. All values were given as
mean SD.
Results
As shown in Figure 1, immediately after 400 mm Hg of TMP
suddenly developed in the hernodiafilter, rapid ultrafiltration
occurred. However, it decreased quickly to reach a stable rate,
which was nearly one-tenth of the initial rate, at 2 seconds
following the development of TMP. The results suggest that
approximately 2 seconds were needed to complete the protein
concentration polarization.
The total ultrafiltration volume was extremely large in push/pull
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Fig. 2. Albumin loss through protein-permeable membrane by push/pull
HDF, conventional HDF and RD. Albumin loss into dialysate was signif-
icantly less by push/pull HDF than by conventional HDF. However, the
albumin loss by push/pull HDF was still significantly greater than that by
HD.
HDF at 128 14 liters, compared to 20.3 1.3 liters in
conventional HDF. Nevertheless, as shown in Figure 2, albumin
loss into the dialysate was significantly less by push/pull HDF at
6.5 0.9 g/treatment than by conventional HDF (18.9 3.5
g/treatment). However, the albumin loss by push/pull HDF was
still significantly greater than that (3.4 0.7 g/treatment) by HD
in which the total ultrafiltration volume was 2.9 0.4 liters.
As shown in Figure 3, the reduction rate of a1AG, which was
the largest tracer substance among the four, was significantly less
by push/pull HDF at 5.4 1.9% than by conventional HDF (19.5
2.8%). However, there were no significant differences in the
reduction rate of prolactin between push/pull HDF and conven-
tional HDF. The reduction rate of prolactin was 55.1 8.2% by
push/pull HDF against 57.4 7.9% by conventional HDF. The
reduction rates of 32m and myoglobin, which are smaller sub-
stances than either a1AG or prolactin, were significantly greater
by push/pull HDF at 74.2 6.3% and 68.6 7.2%, respectively,
than by conventional HDF (67.5 6.5% and 61.0 5.5%,
respectively). The reduction rates of /32m, myoglobin, prolactin
and cs1AG were much less at 59.7 8.8%, 42.1 6.9%, 35.8
5.1% and 2.1 1.4%, respectively, by HD than by push/pull HDF
or conventional HDF.
Discussion
In our in vivo study, it was suggested that approximately 2
seconds were needed for completion of protein concentration
polarization. Now, in push/pull HDF, a single forefiltration was
extremely short at 0.8 to 0.9 seconds [6]. Therefore, in this
treatment, forefiltration is thought to be switched to backfiltration
before completion of concentration polarization. In other words,
the concentrations of a1AG and albumin on the membrane
surface may be consistently lower during push/pull HDF than
during conventional HDF. This may be the reason for the less
albumin loss and less cs1AG removal by push/pull HDF than by
conventional HDF.
In the present study, the reduction rates of 32m and myoglobin
were significantly greater by push/pull HDF using protein-perme-
able membrane than by conventional ITIDF using the same
membrane. Now, the concentration polarization may be weaker
for 132m and myoglobin than for a1AG and albumin, since the
sieving coefficient is much greater for f32m and myoglobin than for
a1AG and albumin. Therefore, prevention of concentration po-
larization may not affect the removal of j32m and myoglobin so
much as it does the removal of a1AG and albumin. Thus, the
ultrafiltration volume may be more important for the removal of
132m and myoglobin than for the removal of cs1AG and albumin.
This may explain the greater reduction rates of f32m and myoglo-
bin by push/pull HDF than by conventional HDF.
The reason the reduction rate of prolactin by push/pull HDF
was equivalent to that by conventional HDF may be that in the
Fig. 3. Reduction rates of various tracer
substances by push/pull HDF, conventional HDF
and HD. The open bar indicates the push/pull
HDF, the closed bar the conventional HDF,
and the dotted bar HD. The reduction rate of
n1AG was significantly less by push/pull HDF
than by conventional HDF. However, there
were no significant differences in the reduction
rate of prolactin between push/pull HDF and
conventional HDF. The reduction rates of f32m
and myoglobin were significantly greater by
push/pull HDF than by conventional HDF. The
reduction rates of 132m, myoglobin, prolactin
and a1AO were all much less by HD than by
push/pull HDF or conventional HDF.
Significant differences: * < 0.05, **p < 0.01,
< 0.001
434 Shinzato et al. Reduced convective albumin loss
1
r* iri r ***_1
I *1r**1
Ct
a
0
80
60
40
20
0
132-microglobulin Myoglobin -acid
glycoprotein
Prolactin
r P<0.00t——- P<0.001
20 1
10
0
Push/pull Conventional HD
HDF HDF
Shinzato et al: Reduced convective albumin loss 435
push/pull HDF, the increased removal of this substance due to the
greater ultrafiltration volume compensated for the decreased
removal of same due to the concentration polarization failure.
The reduction rate of cr1AG was greater by conventional HDF
using protein-permeable membrane than by push/pull HDF using
the same membrane. Nevertheless, the conventional HDF using
the protein-permeable membrane cannot be employed clinically,
because of the excessive loss of albumin.
On the other hand, push/pull HDF using the same membrane
may be clinically useful, since the albumin loss by this treatment is
almost within the acceptable range. The albumin amount lost into
dialysate by push/pull HDF using the protein-permeable mem-
brane was nearly one-third of that by conventional HDF using the
same membrane and comparable with that by CAPD. The albu-
min amount (19.5 g) lost by push/pull HDF in a one-week period,
which was estimated by multiplying the albumin amount lost by a
single treatment by the number of weekly treatments, was almost
equivalent to the reported albumin amount (18.7 g [9]) lost by
CAPD in a one-week period. Nevertheless, the a1AG amount
(1631 mg) removed by push/pull HDF in a one-week period (data
not shown), which was estimated in the same way, was almost two
times the amount (896 mg [9]) reported to be removed by CAPD.
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